18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Sleep Disorders Associated With Alzheimer's Disease: A Perspective

      review-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Sleep disturbances, as well as sleep-wake rhythm disturbances, are typical symptoms of Alzheimer's disease (AD) that may precede the other clinical signs of this neurodegenerative disease. Here, we describe clinical features of sleep disorders in AD and the relation between sleep disorders and both cognitive impairment and poor prognosis of the disease. There are difficulties of the diagnosis of sleep disorders based on sleep questionnaires, polysomnography or actigraphy in the AD patients. Typical disturbances of the neurophysiological sleep architecture in the course of the AD include deep sleep and paradoxical sleep deprivation. Among sleep disorders occurring in patients with AD, the most frequent disorders are sleep breathing disorders and restless legs syndrome. Sleep disorders may influence circadian fluctuations of the concentrations of amyloid-β in the interstitial brain fluid and in the cerebrovascular fluid related to the glymphatic brain system and production of the amyloid-β. There is accumulating evidence suggesting that disordered sleep contributes to cognitive decline and the development of AD pathology. In this mini-review, we highlight and discuss the association between sleep disorders and AD.

          Related collections

          Most cited references68

          • Record: found
          • Abstract: found
          • Article: not found

          Inflammation in neurodegenerative disease--a double-edged sword.

          Inflammation is a defense reaction against diverse insults, designed to remove noxious agents and to inhibit their detrimental effects. It consists of a dazzling array of molecular and cellular mechanisms and an intricate network of controls to keep them in check. In neurodegenerative diseases, inflammation may be triggered by the accumulation of proteins with abnormal conformations or by signals emanating from injured neurons. Given the multiple functions of many inflammatory factors, it has been difficult to pinpoint their roles in specific (patho)physiological situations. Studies of genetically modified mice and of molecular pathways in activated glia are beginning to shed light on this issue. Altered expression of different inflammatory factors can either promote or counteract neurodegenerative processes. Since many inflammatory responses are beneficial, directing and instructing the inflammatory machinery may be a better therapeutic objective than suppressing it.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study.

            To evaluate any association between obesity in middle age, measured by body mass index and skinfold thickness, and risk of dementia later in life. Analysis of prospective data from a multiethnic population based cohort. Kaiser Permanente Northern California Medical Group, a healthcare delivery organisation. 10,276 men and women who underwent detailed health evaluations from 1964 to 1973 when they were aged 40-45 and who were still members of the health plan in 1994. Diagnosis of dementia from January 1994 to April 2003. Time to diagnosis was analysed with Cox proportional hazard models adjusted for age, sex, race, education, smoking, alcohol use, marital status, diabetes, hypertension, hyperlipidaemia, stroke, and ischaemic heart disease. Dementia was diagnosed in 713 (6.9%) participants. Obese people (body mass index > or = 30) had a 74% increased risk of dementia (hazard ratio 1.74, 95% confidence interval 1.34 to 2.26), while overweight people (body mass index 25.0-29.9) had a 35% greater risk of dementia (1.35, 1.14 to 1.60) compared with those of normal weight (body mass index 18.6-24.9). Compared with those in the lowest fifth, men and women in the highest fifth of the distribution of subscapular or tricep skinfold thickness had a 72% and 59% greater risk of dementia, respectively (1.72, 1.36 to 2.18, and 1.59, 1.24 to 2.04). Obesity in middle age increases the risk of future dementia independently of comorbid conditions.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer's disease cases.

              The activity of the glymphatic system is impaired in animal models of Alzheimer's disease (AD). We evaluated the activity of the human glymphatic system in cases of AD with a diffusion-based technique called diffusion tensor image analysis along the perivascular space (DTI-ALPS).
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Neurosci
                Front Neurosci
                Front. Neurosci.
                Frontiers in Neuroscience
                Frontiers Media S.A.
                1662-4548
                1662-453X
                31 May 2018
                2018
                : 12
                : 330
                Affiliations
                [1] 1Department of Pulmonology and Lung Cancer, Wroclaw Medical University , Wroclaw, Poland
                [2] 2Department of Psychiatry, Wroclaw Medical University , Wroclaw, Poland
                [3] 3King Fahd Medical Research Center, King Abdulaziz University , Jeddah, Saudi Arabia
                [4] 4Department of Neurology, Wroclaw Medical University , Wroclaw, Poland
                [5] 5Facultad de Ciencias de la Salud, Universidad del Tolima , Ibagué, Colombia
                [6] 6Department of Biochemistry and Bioinformatics, School of Life Sciences, Institute of Science, Gandhi Institute of Technology and Management University , Visakhapatnam, India
                [7] 7Institute for Pharmaceutical Science and Translational Medicine, Sechenov First Moscow State Medical University , Moscow, Russia
                [8] 8Institute of Physiologically Active Compounds of the Russian Academy of Sciences , Chernogolovka, Russia
                [9] 9Departamento de Nutrición y Bioquímica, Facultad de Ciencias, Pontificia Universidad Javeriana , Bogotá, Colombia
                [10] 10Instituto de Ciencias Biomédicas, Universidad Autónoma de Chile , Santiago, Chile
                [11] 11GALLY International Biomedical Research and Consulting LLC , San Antonio, TX, United States
                [12] 12School of Health Science and Healthcare Administration, University of Atlanta , Johns Creek, GA, United States
                Author notes

                Edited by: Hamid R. Sohrabi, Macquarie University, Australia

                Reviewed by: Stephanie R. Rainey-Smith, Edith Cowan University, Australia; Akifumi Kishi, The University of Tokyo, Japan

                This article was submitted to Neurodegeneration, a section of the journal Frontiers in Neuroscience

                Article
                10.3389/fnins.2018.00330
                5990625
                29904334
                84c5ee46-96a6-4eff-9dcb-7717167646b1
                Copyright © 2018 Brzecka, Leszek, Ashraf, Ejma, Ávila-Rodriguez, Yarla, Tarasov, Chubarev, Samsonova, Barreto and Aliev.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 26 October 2017
                : 30 April 2018
                Page count
                Figures: 2, Tables: 0, Equations: 0, References: 97, Pages: 10, Words: 8603
                Funding
                Funded by: Russian Science Foundation 10.13039/501100006769
                Award ID: 14-23-00160P
                Categories
                Neuroscience
                Mini Review

                Neurosciences
                ad,diagnosis,sleep disorders,disturbance,sleep-rhythm
                Neurosciences
                ad, diagnosis, sleep disorders, disturbance, sleep-rhythm

                Comments

                Comment on this article